Document is current
Any future updates will be listed below
-
Authors
Sánchez-Iglesias, José Luis
Gómez-Hidalgo, Natalia R. https://orcid.org/0000-0002-5115-6668
Bebia, Vicente
Ramirez, José Manuel
Pérez-Benavente, Asunción
Nelson, Gregg
Gil-Moreno, Antonio
- License Information
-
More Information
Article History
Received: 29 May 2022
Accepted: 22 August 2022
First Online: 22 October 2022
Declarations
:
: The Authors declare no financial conflicts of interest. Dr. Nelson reports speaker/advisory fees from Abbott, GSK, 3M and is the Secretary of the ERAS Society. Dr. Ramirez reports speaker/advisory fees from Vegenat, Vifor, Takeda, MSD, Menarini, BD and is the former president of the Spanish ERAS Society (GERM).
: This study was carried out in the Unit of Gynecology Oncology at the Vall d’Hebron Hospital Campus in Barcelona, Spain.
: The medical records of all patients who underwent cytoreductive surgery for advanced ovarian cancer with simultaneous colon or rectal resection from January 2012 to November 2020 were included.
